A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUniversity of Rochester
About this trial
This is a multicenter randomized controlled trial that assesses the efficacy of a decisional intervention \[University of Rochester-Geriatric Oncology assessment for Acute myeloid Leukemia (UR-GOAL)\] compared to an attention control.
Eligibility criteria
Qualifiers
Age ≥60 years (from date of consent, confirmed on electronic medical records)
A new diagnosis of AML
Diagnosis can be based on the International Consensus Classification or World Health Organization
Myeloid sarcoma is allowed
Disqualifiers
A diagnosis of acute promyelocytic leukemia
Patients with psychiatric or cognitive conditions which the treating oncologist believes prohibits informed consent or compliance with study procedures
Prior cancer-directed treatment for AML
Selected by the patient when asked if there is a "family member, partner, friend or caregiver [age 18 or older] with whom you discuss or who can be helpful in healthrelated matters."
Trial design
Treatments tested in this trial
- UR-GOAL
Treatment groups
1,020 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Rochester
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov